Connect with:
Tuesday / November 19. 2024

logo
mobile-logo
HomePosts Tagged "iil"
Agribusiness, Agro chems – Chemicals, Agro chems – Pesticides, Company News, India

The broad-spectrum insecticide protects white grub and termites, which are a big challenge for Indian farmers.

Insecticides (India) Limited (IIL), one of the nation’s leading crop protection and nutrition companies, has unveiled a patented insecticide called Turner with unique properties and residual control, effective against white grub and termites on a variety of crops. 

Turner is an innovative broad-spectrum insecticide that protects white grub and termites, which are a big challenge for Indian farmers. With contact, stomach & repellent properties, Turner will turn out to be a superior tool to fight these insects for the farmers. Turner is a patented product with long-term effectiveness.

Commenting at the launch, Rajesh Aggarwal, Managing Director, IIL, said, “At IIL, we are driven by a strong R&D team, committed to bringing the latest global technologies and introduce novel and sustainable solutions to address Indian farmers’ challenges. Turner is a breakthrough technology promising a leap forward in pest management. We are confident that Turner will help farmers improve their income through effective protection for a superior harvest.”

“Indian growers deserve access to the most advanced solutions to help them achieve better yields. We aim to provide our hardworking farmers with the right product with the best quality possible within their reach.,” Aggarwal further added.

The broad-spectrum insecticide protects white grub and

Agribusiness, Animal Health, Animal Husbandry, India, Live Stock

With an investment of approximately Rs 700 crores the proposed facility is expected to create more than 750 direct and indirect jobs.

Indian Immunologicals Limited (IIL), one of India’s leading biotechnology companies dedicated to manufacturing and supplying life-saving vaccines, has started construction of its new greenfield veterinary vaccine facility to manufacture the Foot and Mouth Disease Vaccine (FMD-Vac) as well as Foot and Mouth Disease + Haemorrhagic Septicaemia Vaccine (FMD+HS-Vac) in Hyderabad’s Genome valley.

This brand-new unit will have a BSL3 facility for the manufacture of Drug substances and a Fill-Finish capability for the production of both drug products FMD vaccine and the FMD+HS vaccine.

Telangana State Industrial Infrastructure Corporation Ltd (TSIIC), a Government of Telangana undertaking had allotted the land to IIL at Biotech Park, Phase III, Karkapatla, Siddipet district in Telangana. The proposed facility has a capacity of 150 million doses/annum of FMD vaccine or FMD+HS vaccine each. With an investment of approximately Rs 700 crores the proposed facility is expected to create more than 750 direct and indirect jobs.

Indian Immunologicals Limited is a subsidiary of the National Dairy Development Board (NDDB). In its more than 40 years of journey, IIL has carved a niche space as a leading “One Health” organization, manufacturing animal and human vaccines. IIL also exports its products to more than 60 countries across the globe.

 Speaking on the occasion, Dr Meenesh Shah, Chairman of NDDB and IIL said, “IIL continues to fulfil the purpose for which it was created by NDDB as a world class vaccine manufacturer. This new vaccine manufacturing facility in Hyderabad is dedicated to the nation and will certainly aid in the eradication of Foot and Mouth Disease in our country. IIL’s ability to discover and manufacture affordable vaccines has saved the exchequer several thousand crores of rupees”.

Dr K Anand Kumar, Managing Director, IIL said, “We are the largest supplier of FMD vaccine to Government of India’s prestigious Livestock Health Disease Control Programme (LHDCP). We are in an exponential growth phase and expected to grow 40 per cent this year alone. In order to sustain the momentum, IIL is seriously considering making additional investments in building infrastructure within India and in other emerging geographies including Africa in a manner to develop tools that will help in control and eradication of diseases.”

With an investment of approximately Rs 700

Agro chems – Pesticides, Company News, India

The insecticide falls in the Green category and is being produced by IIL under the Make in India initiative that would benefit marginal and small farmers in India

Insecticides (India) Limited (IIL), an agrochemical company has announced the insecticide ‘Mission’ which would attack different types of lepidopteran pests affecting sugarcane crops and other crops like paddy, soybean and vegetables.

According to the company statement, the insecticide Mission will be available in granules as well as liquid form. The insecticide falls in the Green category and is being produced by IIL under the Make in India initiative that would benefit marginal and small farmers in India. It was imported earlier. The mission is well designed to control the spread of stem borer and leaf folders in paddy and other crops.

Rajesh Aggarwal, Managing Director, Insecticides (India), said, “We are pleased to launch Mission today under our Make in India Initiative after Torry, Green Label, Dominant and Stunner. The mission is the latest technology insecticide which can be used on a variety of crops and provide good control to farmers against lepidopteran pests, ensuring good crop health and high yield. We are confident that Mission will help our Indian farmers to improve their income through effective protection for a superior harvest.”

The insecticide falls in the Green category

Acquaculture, Animal Health, India, R&D, Sustainability

For the commercial development of a vaccine against Hemorrhagic Septicemia in freshwater fishes

Hyderabad-based Indian Immunologicals Limited (IIL) has announced a partnership with the Central Institute of Freshwater Aquaculture (CIFA), Bhubaneswar, an Indian Council of Agricultural Research (ICAR) Institute for the commercial development of a vaccine against Hemorrhagic Septicemia, also called Aeromonas Septicemia, Ulcer Disease or Red-Sore Disease in freshwater fish.

IIL ventured into the aqua business in October 2022 by launching products for the aquaculture health market dealing with pond management and fish or shrimp gut management and subsequently announced commercial development of fish vaccines with the ICAR-Central Institute of Fisheries Education (CIFE).

Hemorrhagic Septicemia in freshwater fishes is caused by Aeromonas hydrophila, an opportunistic pathogenic bacterium. This infection is the scourge of fresh and brackish water fish farming worldwide and is considered as a significant economic problem in Indian aquaculture over the past decades. All the cultured freshwater fish species in India like rohu, catla, mrigal, silver carp, grass carp, common carp, medium carp, channel catfish, eel, etc. are susceptible to this disease.

Over the years, antibiotics and chemotherapeutics are used for controlling bacterial diseases including A. hydrophila. Now bacterial pathogens have become resistant to these chemicals when used over an extended period and some chemicals pose environmental health hazards. In this context, vaccination is the most promising and environmentally safe concept for controlling diseases.

Speaking on the occasion, Dr K Anand Kumar, Managing Director, Indian Immunologicals Limited said, “We are working at multiple fronts in defining pathways for commercial development of fish vaccines in India”.

For the commercial development of a vaccine

Acquaculture, Company News, Environment, India, Sustainability

Several fish vaccine candidates are currently being evaluated by IIL for commercialisation

Indian Immunologicals Limited, a leading vaccine manufacturer, has announced partnership with Central Institute of Fisheries Education (CIFE), Mumbai and the Indian Council of Agricultural Research (ICAR) Institute for the commercial development of vaccine against common bacterial diseases in freshwater fishes. IIL has forayed into Aqua business in October 2022 by launching products for aquaculture health market dealing with pond management and fish or shrimp gut management.

Speaking on the occasion, Dr K Anand Kumar, Managing Director, Indian Immunologicals Limited said, “IIL has introduced several innovative veterinary vaccines first to the world, like Porcine Cysticercosis vaccine, FMD+HS+BQ combination vaccine and Theileria vaccine. IIL is again the first in India to get to fish vaccines. We are committed to introducing more and more products for the aquaculture market and help shrimp and fish growers to increase their productivity and protect fish schools from various diseases”.

IIL strive to explore solutions for the prevailing challenges faced by Indian fish farmers in their farm production system. CIFE will provide technology for two inactivated bacterial vaccines, one for Columnaris Disease, a serious condition affecting numerous freshwater fish species, and other for Edwardsiellosis that cause high degree of mortality, leading to severe economic losses. Both the diseases are extremely common in freshwater fishes and is generally considered to be ubiquitous.

Dr Priyabrata Pattnaik, Deputy Managing Director, Indian Immunologicals Limited added “IIL is planning to introduce vaccines and immunostimulants with tech transfer from various fisheries institutes under ICAR. Several fish vaccine candidates are currently being evaluated by IIL for commercialisation. Launch of such vaccines may have a positive impact on reducing indiscriminate use of chemical or antibiotic based treatment methods, helping reduce antimicrobial resistance by fish farmers practicing environmentally sustainable ways of pond and fish health management”.

Dr CN Ravishankar, Director and Vice Chancellor of ICAR-CIFE said “In support to India’s Blue Revolution, I am glad that CIFE and IIL have come together to partner in developing India’s fist bacterial fish vaccine”.

Several fish vaccine candidates are currently being

Agro chems – Pesticides, Agro Universities, Agrotech

The MoU will aid in advanced agri-extension activities and farmer awareness for three years

Insecticides (India) Limited (IIL)’s CSR wing IIL Foundation has signed an MoU with Sardar Vallabhbhai Patel University of Agriculture & Technology (SVPUAT), Meerut, UP for dissemination of the advanced agri-extension activities and farmer awareness for three years.

In the signing ceremony programme organised at the university campus, the MoU was signed by Dr RK Mittal, Vice-Chancellor and Sandeep Aggarwal on behalf of the IIL Foundation.

Under this MoU, IIL Foundation will work with Krishi Vigyan Kendra under the Directorate of Extension of the University for education and awareness of the judicious use of crop protection products. This will help the farmers to learn the new and modern practices and increase their productivity.

From Insecticides (India), Sandeep Aggarwal, CFO, Insecticides (India) and trustee of IIL Foundation, MK Singhal, Vice President, Insecticides (India), Sanjay Singh, Sr GM, Insecticides (India) and Dr Charan Singh, Project Charge, IIL foundation were present among other team members.

The MoU will aid in advanced agri-extension

Live Stock

The vaccine is expected to help control of Goat Pox disease in the country

Indian Immunologicals Limited (IIL), a leading vaccine manufacturer base out of Hyderabad, has launched ‘Goat Pox Vaccine (Raksha Goat Pox)’ for the significant Goat population in the country. Raksha Goat Pox vaccine is expected to help control of Goat Pox disease in the country, which has high economic importance among country’s rural livestock growers.

IIL’s Raksha Goat Pox vaccine is a live attenuated vaccine IP (Uttarkashi strain) grown on Vero Cell Culture. The Primary vaccination to be done at 3 months of age and revaccination annually with a dose rate of 1 ml, to be administered subcutaneously.  The technology for vaccine manufacturing and testing of Goat Pox Vaccine was obtained from Indian Council of Agriculture Research – Indian Veterinary Research Institute (ICAR- IVRI), Government of India and has been tested and certified by IVRI for commercial release.  

Speaking on the occasion from the launch, Managing Director of IIL, Dr K Anand Kumar said, “Indian Immunologicals is committed to introducing such products for the national interest and will abundantly help marginal livestock growers of their livelihood and protect their flock from various diseases“. Dr Priyabrata Pattnaik, Deputy Managing Director and Sobhan Babu, Vice President – Animal Health Trade of IIL were also present in the Goat Pox Vaccine launch event.

Earlier IIL launched several other vaccines such as Classical Swine Fever vaccine, PPR Vaccine etc under tech transfer arrangement with IVRI. 

The vaccine is expected to help control